Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

Yang Liu; Fangfang Yan; Vivian Changying Jiang; Yijing Li; Yuxuan Che; Joseph McIntosh; Alexa Jordan; Ian Hou; Lei Nie; Jingling Jin; Wei Wang; Heng Huan Lee; Yixin Yao; Michael Wang

doi:10.3324/haematol.2022.282031

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

Yang Liu, Fangfang Yan, Vivian Changying Jiang, Yijing Li, Yuxuan Che, Joseph McIntosh, Alexa Jordan, Ian Hou, Lei Nie, Jingling Jin, Wei Wang, Heng Huan Lee, Yixin Yao, Michael Wang

Lymphoma-Myeloma

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1412-1416
Number of pages	5
Journal	Haematologica
Volume	108
Issue number	5
DOIs	https://doi.org/10.3324/haematol.2022.282031
State	Published - May 2023

ASJC Scopus subject areas

Hematology

MD Anderson CCSG core facilities

Research Animal Support Facility
Functional Proteomics Reverse Phase Protein Array Core
Bioinformatics Shared Resource

Access to Document

10.3324/haematol.2022.282031

Cite this

Liu, Y., Yan, F., Jiang, V. C., Li, Y., Che, Y., McIntosh, J., Jordan, A., Hou, I., Nie, L., Jin, J., Wang, W., Lee, H. H., Yao, Y., & Wang, M. (2023). Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma. Haematologica, 108(5), 1412-1416. https://doi.org/10.3324/haematol.2022.282031

Liu, Y, Yan, F, Jiang, VC, Li, Y, Che, Y, McIntosh, J, Jordan, A, Hou, I, Nie, L , Jin, J, Wang, W, Lee, HH , Yao, Y & Wang, M 2023, 'Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma', Haematologica, vol. 108, no. 5, pp. 1412-1416. https://doi.org/10.3324/haematol.2022.282031

@article{1d21e89e669c411fad163496fd179785,

title = "Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma",

author = "Yang Liu and Fangfang Yan and Jiang, {Vivian Changying} and Yijing Li and Yuxuan Che and Joseph McIntosh and Alexa Jordan and Ian Hou and Lei Nie and Jingling Jin and Wei Wang and Lee, {Heng Huan} and Yixin Yao and Michael Wang",

note = "Funding Information: This work was supported by an SRA grant from LOXO Oncology at",

year = "2023",

month = may,

doi = "10.3324/haematol.2022.282031",

language = "English (US)",

volume = "108",

pages = "1412--1416",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "5",

}

TY - JOUR

T1 - Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

AU - Liu, Yang

AU - Yan, Fangfang

AU - Jiang, Vivian Changying

AU - Li, Yijing

AU - Che, Yuxuan

AU - McIntosh, Joseph

AU - Jordan, Alexa

AU - Hou, Ian

AU - Nie, Lei

AU - Jin, Jingling

AU - Wang, Wei

AU - Lee, Heng Huan

AU - Yao, Yixin

AU - Wang, Michael

N1 - Funding Information: This work was supported by an SRA grant from LOXO Oncology at

PY - 2023/5

Y1 - 2023/5

UR - http://www.scopus.com/inward/record.url?scp=85151995458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85151995458&partnerID=8YFLogxK

U2 - 10.3324/haematol.2022.282031

DO - 10.3324/haematol.2022.282031

M3 - Letter

C2 - 36475521

AN - SCOPUS:85151995458

SN - 0390-6078

VL - 108

SP - 1412

EP - 1416

JO - Haematologica

JF - Haematologica

IS - 5

ER -

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Cite this